Drawing for EXSCIENTIA

USPTO serial 79263582

EXSCIENTIA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MORRIS, KRISTINA KLOIBER
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EXSCIENTIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ellie Sowanick

Ellie Sowanick Haynes and Boone, LLP2323 Victory Ave., Suite 700Dallas, TX 75219UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of pain, viruses, cancer, mental and physical disorders and conditions, skin conditions, infections, respiratory conditions, anxiety, arthritis, neurological disease, muscular disease, diseases of the nervous system, diseases and disorders of the cardiovascular system; veterinary preparations for the treatment of pain, viruses, wounds, cancer, mental and physical disorders and conditions, muscular disease, cardiovascular disease, skin conditions, infections, respiratory conditions, arthritis, inflammation, allergies, and anxiety; veterinary preparations, namely, vaccines for animals; and sanitary substances for medical use, all of the aforesaid developed using artificial intelligence technologyACTIVE—
042Bioinformatic services, namely, collecting and analyzing complex biological data through the use of artificial intelligence; computer assisted molecule design involving the use of artificial intelligence technology; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for the combatting of diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 25, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 1, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 4, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 2, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 24, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 18, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Nov 8, 2021FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 21, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 21, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 22, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 30, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 30, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 21, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 21, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 8, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 8, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 8, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 5, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 27, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 13, 2019RFNTREFUSAL PROCESSED BY IB—
Aug 27, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 27, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 3, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 2, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 30, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 26, 2019DOCKASSIGNED TO EXAMINER—
Jul 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance